The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies

Tissue Factor: Catch Me If You Can!

(2017) Cihan Ay et al.   JOURNAL OF CLINICAL ONCOLOGY

The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies

(2016) S. Sciascia et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome

(2016) Maria Laura Bertolaccini et al.   JOURNAL OF AUTOIMMUNITY

The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study

(2015) Arsène Mekinian et al.   AUTOIMMUNITY REVIEWS

New insights into mechanisms of therapeutic effects of antimalarial agents in SLE

(2012) Daniel J. Wallace et al.   Nature Reviews Rheumatology

Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome

(2012) Paul Seed et al.   THROMBOSIS AND HAEMOSTASIS

Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression

(2011) Xiao-Xuan Wu et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

A novel antiphospholipid antibody agent?

(2010) B. J. Hunt   BLOOD

Antiphospholipid syndrome

(2010) Guillermo Ruiz-Irastorza et al.   LANCET

Tissue Factor and Its Measurement in Whole Blood, Plasma, and Microparticles

(2010) Nigel Key et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

(2009) J. H. Rand et al.   BLOOD

Hydroxychloroquine directly reduces the binding of antiphospholipid antibody- 2-glycoprotein I complexes to phospholipid bilayers

(2008) J. H. Rand et al.   BLOOD